Opportunities for PROCEPT BioRobotics Investors Amid New Securities Fraud Lawsuit

In a significant development for investors, the Rosen Law Firm, renowned for advocating investor rights, is calling attention to the ongoing class action lawsuit involving PROCEPT BioRobotics Corporation (NASDAQ: PRCT). This lawsuit is directed at those who purchased shares between February 28, 2024, and February 25, 2026, and now find themselves facing substantial losses exceeding $100,000. This group of investors holds the opportunity to possibly lead the lawsuit, which seeks to address allegations of securities fraud against the company.

Understanding the Allegations

The lawsuit alleges that during the specified Class Period, PROCEPT BioRobotics made several misleading statements that directly impacted the company's stock performance and investor trust. Key to these allegations are claims that the company significantly overstated its sales figures and misrepresented the demand for its handpiece units. Specifically, the accusations include:

1. Inflated Sales Figures: The company purportedly utilized a discount program that artificially boosted its reported sales figures. This was meant to incentivize customers to place bulk orders, leading to inflated reporting of U.S. handpiece unit sales.

2. Exaggerated Revenue Forecasts: Due to the inflated sales, the lawsuit suggests that PROCEPT was not able to meet its projected sales and revenue guidance for 2025. This discrepancy highlights a lack of factual basis behind the company's public assertions.

3. Creating a Sales Glut: The extensive discount program, while initially beneficial for driving sales, reportedly led to a surplus of inventory. By the end of the Class Period, inventory levels had allegedly grown to over 10,000 excess units, creating operational pressures that could jeopardize future earnings.

These allegations, if confirmed, could likely lead to severe repercussions for the company and yield significant recoveries for affected investors.

Deadlines and Next Steps

The lead plaintiff deadline for the class action lawsuit is September 22, 2026. Interested investors are encouraged to act swiftly to join the class action. They can do so by visiting the Rosen Law Firm's dedicated webpage for this lawsuit or contacting Phillip Kim, Esq., toll-free at 866-767-3653. Joining the lawsuit does not require upfront fees, as the Rosen Law Firm operates on a contingency fee basis, meaning they only collect fees if the lawsuit is successful.

Why Choose Rosen Law Firm

When selecting legal representation in matters of securities litigation, it is crucial to choose a firm with proven experience and a track record of success. The Rosen Law Firm has represented investors globally and has notable accomplishments in securing large settlements in precedent-setting cases. They achieved one of the largest settlements in a case against a Chinese company and have consistently ranked at the top of securities class action settlements by ISS Securities Class Action Services.

The Process Ahead

For those looking to get involved, it's important to remember that a class has not yet been certified. Investors are not represented by counsel unless they retain one, so options remain open for individuals to choose their representation or remain as absent class members.

As the clock ticks down to the September deadline, proactive engagement is key. Current and former shareholders who bought PROCEPT shares during the specified timeframe may be entitled to recover their losses, and the outcome of this lawsuit could set an important precedent for investor rights in security cases.

Conclusion

As details concerning the allegations come to light and the class action progresses, affected investors must stay informed and take necessary actions. For continuous updates and further developments, interested parties may follow the Rosen Law Firm on their various social media platforms, ensuring they are always up to date with the latest information and guidance.

Through collective effort and shared experience, investors may find the path to recovery and justice in the aftermath of these serious allegations.